))
Lilly Earnings Call: Zepbound and Mounjaro Updates
Manage episode 415747735 series 3550124
Contenu fourni par Dave Knapp Man On The Mounjaro. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dave Knapp Man On The Mounjaro ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Dave Knapp does a deep dive into todays Eli Lilly earnings call.
https://www.onthepen.com/post/zepbound-vial-watch-eli-lilly-earnings-q1-2024
MY WORK RELIES ON YOUR GENEROSITY, BECOME A MEMBER HERE:
https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join
Venmo: OnThePen
Ca$h App: ManOnMounjaro
SOCIAL LINKS
https://www.tiktok.com/@manonthemounjaro
https://twitter.com/ManOnMounjaro
https://instagram.com/manonthemounjaro
https://facebook.com/manonthemounjaro
Thank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!
26 episodes
Partager
